These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 19464519)

  • 1. Measurement of plasmalemmal dopamine transport, vesicular dopamine transport, and K(+)-stimulated dopamine release in frozen rat brain tissue.
    Volz TJ; Farnsworth SJ; Hanson GR; Fleckenstein AE
    J Neurosci Methods; 2009 Jun; 180(2):317-20. PubMed ID: 19464519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurement of kinetically resolved vesicular dopamine uptake and efflux using rotating disk electrode voltammetry.
    Volz TJ; Hanson GR; Fleckenstein AE
    J Neurosci Methods; 2006 Jul; 155(1):109-15. PubMed ID: 16480775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylenedioxymethamphetamine decreases plasmalemmal and vesicular dopamine transport: mechanisms and implications for neurotoxicity.
    Hansen JP; Riddle EL; Sandoval V; Brown JM; Gibb JW; Hanson GR; Fleckenstein AE
    J Pharmacol Exp Ther; 2002 Mar; 300(3):1093-100. PubMed ID: 11861820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of the vesicular monoamine transporter-2: a novel mechanism for cocaine and other psychostimulants.
    Brown JM; Hanson GR; Fleckenstein AE
    J Pharmacol Exp Ther; 2001 Mar; 296(3):762-7. PubMed ID: 11181904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylphenidate-induced increases in vesicular dopamine sequestration and dopamine release in the striatum: the role of muscarinic and dopamine D2 receptors.
    Volz TJ; Farnsworth SJ; Rowley SD; Hanson GR; Fleckenstein AE
    J Pharmacol Exp Ther; 2008 Oct; 327(1):161-7. PubMed ID: 18591219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presynaptic control of striatal dopamine neurotransmission in adult vesicular monoamine transporter 2 (VMAT2) mutant mice.
    Patel J; Mooslehner KA; Chan PM; Emson PC; Stamford JA
    J Neurochem; 2003 May; 85(4):898-910. PubMed ID: 12716422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylphenidate administration alters vesicular monoamine transporter-2 function in cytoplasmic and membrane-associated vesicles.
    Volz TJ; Farnsworth SJ; King JL; Riddle EL; Hanson GR; Fleckenstein AE
    J Pharmacol Exp Ther; 2007 Nov; 323(2):738-45. PubMed ID: 17693585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced Dopamine Release by Dopamine Transport Inhibitors Described by a Restricted Diffusion Model and Fast-Scan Cyclic Voltammetry.
    Hoffman AF; Spivak CE; Lupica CR
    ACS Chem Neurosci; 2016 Jun; 7(6):700-9. PubMed ID: 27018734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cocaine alters vesicular dopamine sequestration and potassium-stimulated dopamine release: the role of D2 receptor activation.
    Farnsworth SJ; Volz TJ; Hanson GR; Fleckenstein AE
    J Pharmacol Exp Ther; 2009 Mar; 328(3):807-12. PubMed ID: 19038779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cocaine-induced increases in vesicular dopamine uptake: role of dopamine receptors.
    Brown JM; Hanson GR; Fleckenstein AE
    J Pharmacol Exp Ther; 2001 Sep; 298(3):1150-3. PubMed ID: 11504813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bupropion increases striatal vesicular monoamine transport.
    Rau KS; Birdsall E; Hanson JE; Johnson-Davis KL; Carroll FI; Wilkins DG; Gibb JW; Hanson GR; Fleckenstein AE
    Neuropharmacology; 2005 Nov; 49(6):820-30. PubMed ID: 16005476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Halothane increases non-vesicular [(3)H]dopamine release from brain cortical slices.
    Diniz PH; Silva JH; Gomez MV; Guatimosim C; Gomez RS
    Cell Mol Neurobiol; 2007 Sep; 27(6):757-70. PubMed ID: 17680357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-dependent differences in dopamine transporter and vesicular monoamine transporter-2 function and their implications for methamphetamine neurotoxicity.
    Volz TJ; Farnsworth SJ; Rowley SD; Hanson GR; Fleckenstein AE
    Synapse; 2009 Feb; 63(2):147-51. PubMed ID: 19021208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Demon voltammetry and analysis software: analysis of cocaine-induced alterations in dopamine signaling using multiple kinetic measures.
    Yorgason JT; España RA; Jones SR
    J Neurosci Methods; 2011 Nov; 202(2):158-64. PubMed ID: 21392532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Method development and validation of an in vitro model of the effects of methylphenidate on membrane-associated synaptic vesicles.
    Volz TJ; Farnsworth SJ; Hanson GR; Fleckenstein AE
    J Neurosci Methods; 2009 Feb; 177(1):177-82. PubMed ID: 18992277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methamphetamine alters vesicular monoamine transporter-2 function and potassium-stimulated dopamine release.
    Chu PW; Hadlock GC; Vieira-Brock P; Stout K; Hanson GR; Fleckenstein AE
    J Neurochem; 2010 Oct; 115(2):325-32. PubMed ID: 20649837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lobelane inhibits methamphetamine-evoked dopamine release via inhibition of the vesicular monoamine transporter-2.
    Nickell JR; Krishnamurthy S; Norrholm S; Deaciuc G; Siripurapu KB; Zheng G; Crooks PA; Dwoskin LP
    J Pharmacol Exp Ther; 2010 Feb; 332(2):612-21. PubMed ID: 19855096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylphenidate redistributes vesicular monoamine transporter-2: role of dopamine receptors.
    Sandoval V; Riddle EL; Hanson GR; Fleckenstein AE
    J Neurosci; 2002 Oct; 22(19):8705-10. PubMed ID: 12351745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A single methamphetamine administration rapidly decreases vesicular dopamine uptake.
    Brown JM; Riddle EL; Sandoval V; Weston RK; Hanson JE; Crosby MJ; Ugarte YV; Gibb JW; Hanson GR; Fleckenstein AE
    J Pharmacol Exp Ther; 2002 Aug; 302(2):497-501. PubMed ID: 12130707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lobeline displaces [3H]dihydrotetrabenazine binding and releases [3H]dopamine from rat striatal synaptic vesicles: comparison with d-amphetamine.
    Teng L; Crooks PA; Dwoskin LP
    J Neurochem; 1998 Jul; 71(1):258-65. PubMed ID: 9648873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.